Stay updated on Frailty-guided Dosing in Myeloma Clinical Trial

Sign up to get notified when there's something new on the Frailty-guided Dosing in Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Frailty-guided Dosing in Myeloma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.
    Difference
    13%
    Check dated 2025-10-05T10:12:55.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.3%
    Check dated 2025-09-28T03:16:25.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2 (from v3.0.1), and the Back to Top element has been removed.
    Difference
    0.8%
    Check dated 2025-09-13T17:39:05.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.8%
    Check dated 2025-09-06T15:20:47.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information.
    Difference
    12%
    Check dated 2025-08-30T12:04:04.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.3%
    Check dated 2025-08-16T04:43:25.000Z thumbnail image

Stay in the know with updates to Frailty-guided Dosing in Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Frailty-guided Dosing in Myeloma Clinical Trial page.